K Xu, M Zhang, S Yang, G Yu, P Zheng, X Qin, J Feng - BMC neurology, 2023 - Springer
Background Teriflunomide, the active metabolite of leflunomide, is a disease-modifying
therapy drug used for the treatment of multiple sclerosis (MS), yet the complications …